Ignite Creation Date:
2025-12-25 @ 5:03 AM
Ignite Modification Date:
2026-01-26 @ 9:43 PM
Study NCT ID:
NCT04701918
Status:
RECRUITING
Last Update Posted:
2025-12-15
First Post:
2020-12-14
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Cryoablation With Pembrolizumab Or Avelumab In Urothelial Carcinoma
Sponsor:
Massachusetts General Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
20-531
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |